Yasuhiro Hasegawa Selected Research

Thrombolytic Therapy

11/2018	A case of cerebral infarction during a hemodialysis procedure successfully treated with recombinant tissue plasminogen activator.
9/2018	Rheumatoid meningitis presenting with a stroke-like attack treated with recombinant tissue plasminogen activator: a case presentation.
1/2017	Prehospital triage for endovascular clot removal in acute stroke patients.
5/2013	Prediction of thrombolytic therapy after stroke-bypass transportation: the Maria Prehospital Stroke Scale score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Hasegawa Research Topics

Disease

57	Stroke (Strokes) 10/2023 - 01/2004
30	Ischemic Stroke 11/2023 - 09/2007
14	Cerebral Hemorrhage 01/2021 - 09/2009
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 04/2010
10	Atrial Fibrillation 07/2019 - 01/2011
7	Hemorrhage 12/2023 - 03/2014
7	Pathologic Constriction (Stenosis) 05/2023 - 11/2009
7	Neoplasms (Cancer) 01/2022 - 09/2014
7	Disease Progression 01/2021 - 03/2002
6	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2008
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2023 - 10/2017
5	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 01/2013
4	Infections 04/2023 - 05/2007
4	Spinal Cord Diseases 01/2023 - 01/2014
4	Hyperplasia 08/2022 - 05/2019
4	Inflammation (Inflammations) 01/2022 - 09/2013
4	Infarction (Infarctions) 11/2021 - 08/2015
4	Hematoma 01/2021 - 12/2012
4	Embolism (Embolus) 01/2020 - 01/2016
4	Pain (Aches) 04/2019 - 03/2002
4	Brain Infarction 04/2019 - 01/2003
4	Transient Ischemic Attack 01/2019 - 08/2015
3	Demyelinating Diseases (Demyelinating Disease) 03/2023 - 01/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2011
3	Acute Coronary Syndrome 01/2020 - 01/2012
3	Hyperglycemia 12/2019 - 11/2009
3	Migraine Disorders (Migraine) 09/2019 - 09/2013
3	Hypertension (High Blood Pressure) 01/2018 - 01/2011
3	Heart Failure 11/2009 - 09/2004
2	Pruritus (Itching) 02/2024 - 07/2014
2	Aneurysm (Aneurysms) 11/2023 - 08/2021
2	Lymphopenia (Lymphocytopenia) 01/2023 - 01/2021
2	Guillain-Barre Syndrome 11/2022 - 01/2013
2	Thrombosis (Thrombus) 11/2022 - 04/2016
2	Lymphadenopathy 01/2022 - 01/2016
2	Dementia (Dementias) 01/2022 - 09/2019
2	Fever (Fevers) 01/2021 - 12/2020
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 01/2019
2	Multiple Sclerosis 12/2020 - 07/2016
2	Consciousness Disorders 12/2020 - 01/2014
2	Dysarthria (Spastic Dysarthria) 08/2020 - 12/2017
2	Hypoglycemia (Reactive Hypoglycemia) 07/2020 - 12/2019
2	Hypoxia (Hypoxemia) 01/2020 - 10/2004
2	Anemia 01/2020 - 04/2011
2	Headache (Headaches) 09/2019 - 01/2014
2	Paresis (Hemiparesis) 04/2019 - 01/2014
2	Rheumatoid Arthritis 04/2019 - 10/2017
2	Biliary Atresia 03/2019 - 01/2018
2	Seizures (Absence Seizure) 01/2019 - 01/2014
2	Cerebral Infarction 11/2018 - 03/2018
2	Body Weight (Weight, Body) 01/2018 - 11/2014
2	Embolic Stroke 02/2017 - 11/2006
2	Atrophy 01/2016 - 03/2004
2	MELAS Syndrome (Syndrome, MELAS) 01/2016 - 01/2014

Drug/Important Bio-Agent (IBA)

24	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 01/2009
9	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 09/2009
9	Warfarin (Coumadin)FDA LinkGeneric 07/2019 - 01/2012
9	AnticoagulantsIBA 07/2019 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
7	SteroidsIBA 01/2021 - 01/2014
5	Vitamin K FDA Link 04/2016 - 01/2015
4	Interleukin-6 (Interleukin 6)IBA 03/2023 - 01/2011
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 10/2017
4	C-Reactive ProteinIBA 01/2022 - 04/2013
4	Blood Glucose (Blood Sugar)IBA 07/2020 - 01/2009
4	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 04/2010
3	fibrin fragment D (D-dimer)IBA 04/2023 - 12/2020
3	AutoantibodiesIBA 03/2023 - 01/2022
3	mogamulizumabIBA 01/2023 - 01/2015
3	Indicators and Reagents (Reagents)IBA 10/2019 - 06/2004
3	Methylprednisolone FDA LinkGeneric 06/2019 - 01/2013
3	3-Iodobenzylguanidine (Iobenguane)IBA 11/2018 - 01/2008
3	Nicardipine (Dagan)FDA LinkGeneric 01/2018 - 12/2012
3	Dabigatran FDA Link 04/2016 - 09/2015
3	LipidsIBA 01/2012 - 01/2011
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2023 - 01/2011
2	cupric sulfide (CuS)IBA 01/2023 - 05/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 11/2022 - 01/2013
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2021 - 02/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 10/2017
2	AcidsIBA 01/2021 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 10/2020 - 01/2016
2	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 06/2020 - 07/2014
2	NeopterinIBA 01/2020 - 01/2013
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2014
2	ChemokinesIBA 01/2019 - 09/2013
2	N(4)-oleylcytosine arabinosideIBA 04/2016 - 01/2015
2	apixabanIBA 01/2016 - 09/2015

Therapy/Procedure

45	Therapeutics 02/2024 - 04/2006
6	Stents 05/2023 - 04/2017
5	Thrombectomy 07/2023 - 07/2018
5	Secondary Prevention 01/2018 - 08/2005
4	Punctures 11/2023 - 04/2019
4	Thrombolytic Therapy 11/2018 - 05/2013
3	Carotid Endarterectomy 08/2022 - 01/2020
2	Gastrectomy 01/2022 - 04/2011
2	Plasmapheresis 01/2019 - 01/2003
2	Renal Dialysis (Hemodialysis) 11/2018 - 01/2015